Clinical Trial Update: Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Update on a Phase 2 study of Apatinib in RET fusion-positive advanced non-small cell lung cancer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Tongji University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN